Earnings

Technical Indicators Turn Indifferent For Repros Therapeutics (NASDAQ:RPRX)

Repros Therapeutics Inc. (NASDAQ:RPRX) gained 0.08% in trading on July 18, 2017, going up from its prior closing price of $0.39 to $0.39 The stock price went upward in 6 of the last 10 days , but has retreated -12.65% over the same course of time. Trading activity decreased by -4.48 million shares, and in total, 1.48 M shares exchanged hands for about $571 802. It should be noted that increasing price and decreasing volume show lack of interest and this is a warning that something has fundamentally changed.

Inside RPRX’s Recent Trend

Repros Therapeutics Inc. (RPRX) lies in the middle of a very wide and falling trend in the short term and pointed towards extra losses. Short-term traders are anticipated to see a retreat of -53.74% over the course of a quarter and, with 90% chance the price will be floating in the range of $0.04 and $0.26 in this timeframe.

Repros Therapeutics Inc. Technical Signals



RPRX has witnessed its long term and short term MA triggering a sell signal. Upon corrections, the price will meet resistance from the averages between $0.52 and $0.44. A buy signal will be generated if it crosses above any of these levels. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Repros Therapeutics Inc. (NASDAQ:RPRX) Support And Resistance Levels

Repros Therapeutics Inc. (RPRX) recorded volume accumulation so there will probably be a surplus of buyers at $0.39, $0.37, and $0.36. In case of gains, the next resistance from accumulated volume will be at $0.41, $0.46 and $0.44.




Repros Therapeutics Inc. (RPRX) Risk Assessment

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be high risk. In the most recent session, the stock price hovered around $0.05 between high and low, or 13.89%. For the last week the stock has had a daily average volatility of 17.91%.

 

Previous ArticleNext Article

Related Post

Are Investors Buying or Selling Platform Specialty... Recent insider trends for Platform Specialty Products Corporation (NYSE:PAH) have caught the attention of investors. Insider data is useful because it...
Ampio Pharmaceuticals, Inc. (AMPE) and Egalet Corp...   Ampio Pharmaceuticals, Inc. (NYSE:AMPE) shares are up more than 365.45% this year and recently increased 15.75% or $0.57 to settle at $4.19....
Comparing Hologic, Inc. (HOLX) and Accuray Incorpo... Hologic, Inc. (NASDAQ:HOLX) shares are up more than 0.82% this year and recently decreased -0.78% or -$0.32 to settle at $40.45. Accuray Incorporated ...
Should You Buy KBR, Inc. (KBR) or Jacobs Engineeri... KBR, Inc. (NYSE:KBR) shares are up more than 6.61% this year and recently increased 3.07% or $0.63 to settle at $21.14. Jacobs Engineering Group Inc. ...
Critical Comparison: Cree, Inc. (CREE) vs. Entegri... Cree, Inc. (NASDAQ:CREE) and Entegris, Inc. (NASDAQ:ENTG) are the two most active stocks in the Semiconductor Equipment & Materials industry based...

Leave a Reply

Your email address will not be published.